Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S. M.R.C.P (UK), M.C.C.E.E (Canada), F.C.P.S (Medicine)
General Physician
MBBS, F.C.P.S.
Diabetologist
M.B.B.S, Dip. In Diabetes
General Physician
M.B.B.S., Certified Diabetologist , Certified Hypertension Specialist
General Physician
M.B.B.S., Certified Diabetologist , Certified Hypertension Specialist
General Physician
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P (UK)
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine)
Diabetologist
MD
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures